Airman Readiness Medical Research (ARMR) Hybrid Broad Agency Announcement (BAA)

BAA Amendment 3, 19 September 2023:

THIS IS AN ANNUAL NOTICE OF AN OPEN BAA AS REQUIRED BY FAR 35.016.

White Papers are still being accepted against this BAA. Please see the Broad Agency Announcement, as amended, for specific details on submitting white papers.

This Amendment encompasses the following changes:

1. Broad Agency Announcement (BAA)

a)  Due to the number of revisions in Amendment 3, refer to the “Tracked Changes” version which is provided for ease of identifying the specific changes that have been made since the previous amendment. 

2. BAA Attachments

a)  The following attachments are included in this BAA. Attachments have been amended or added as annotated in bold font. 

1. Supplemental Instructions for Assistance Instrument Proposal (AMENDED)

2. Model Assistance Instrument (AMENDED)

3. Model Contract (AMENDED)

4. Model Section K – Representations and Certifications (AMENDED)

5. Model Section L – Instructions, Conditions, and Notices to Offerors (AMENDED)

6. Proposal Adequacy Checklist (AMENDED)

7. Contract Data Requirements List (CDRLs) DD Form 1423-1 (AMENDED)

8. Statement of Objectives (SOO) (NO CHANGE)

9. Statement of Work (SOW) Supplemental Requirements (AMENDED)

10. Standard Form (SF) 424 Form, Research and Related Senior/Key Person Profile  (Expanded) Form (ADDED)

11. Security Program Questionnaire (ADDED)

**The Government is providing a model contract and model Assistance Agreement for planning and estimating purposes only. Each award will be tailored to each specific proposal. The attached model contract is all-encompassing of multiple types of contracts and is provided to identify all provisions and clauses that may be included in subsequent awards.

------------------------------------------------------------------------------------------------------------------------------------

BAA Amendment 2, 14 July 2023:

Call 1 to the initial BAA is closed.  As a result of the issuance of this Amendment, Objective 4: "Expeditionary Medicine (EM), Aim 2, Medical Logistics" of the BAA is re-opened.  All areas of the Statement of Objectives are open. 

An annual update is forthcoming and will be issued in a subsequent amendment. 

--------------------------------------------------------------------------------------------------------------------------------------

This is Call 1, "Joint Multi-channel Infusion Pump (JMCIP)" to the initial Broad Agency Announcement (BAA), FA8650-20-S-6008. This is a Two-Step Call for the specific research objective 4, Expeditionary Medicine (EM), Aim 2, Medical Logistics of the BAA. Research objective 4, Aim 2, will be closed off from the Open BAA Period until award of the resulting proposal(s) from this Call. 

This Call is effective as of the date of this posting, 18 February 2022. White papers are due no later than 5:00 p.m. Eastern Standard Time (EST) on 10 March 2022. Please submit white papers via email to the Contracting POCs for the Call, Ms. Marina Schemmel at marina.schemmel@us.af.mil and Ms. Kimberly Cerney at kimberly.cerney@us.af.mil. 

Technical POC for this Call:  Mr. Nathaniel Baldwin, nathaniel.baldwin.1@us.af.mil

Contracting POCs for this Call:  Ms. Marina Schemmel, marina.schemmel@us.af.mil and Ms. Kimberly Cerney, kimberly.cerney@us.af.mil

________________________________________________________________________________________________________

The Warfighter Medical Optimization Division (RHM) intends to solicit White Papers under this announcement with the focus of conducting medical research in support of optimizing the warfighter by enabling, enhancing, restoring, and sustaining the Airman to more effectively execute the Air Force mission. This medical research objective is dual natured: (1) ensure medical availability of Airmen by analyzing attributes (sensory, behavioral, physiologic) and operational environments (chemical, physical, psychological, biological, radiological stressors) to drive optimal performance of Airmen engaged in high-demand, high-impact mission tasks (2) investigate how the flight environment affects the process of life, the ability to maintain homeostasis, and the risk for injury or secondary insult, seeking to ameliorate these stressors to optimize Airman health and performance.

This BAA will remain open for seventy-two (72) months with Calls being released throughout the seventy-two (72) month period of performance. 

BAA Amendment 2, 14 July 2023:

Call 1 to the initial BAA is closed.  As a result of the issuance of this Amendment, Objective 4: "Expeditionary Medicine (EM), Aim 2, Medical Logistics" of the BAA is re-opened.  All areas of the Statment of Objectives are open. 

An annual update is forthcoming and will be issued in a subsequent amendment. 

--------------------------------------------------------------------------------------------------------------------------------------

This is Call 1, "Joint Multi-channel Infusion Pump (JMCIP)" to the initial Broad Agency Announcement (BAA), FA8650-20-S-6008. This is a Two-Step Call for the specific research objective 4, Expeditionary Medicine (EM), Aim 2, Medical Logistics of the BAA. Research objective 4, Aim 2, will be closed off from the Open BAA Period until award of the resulting proposal(s) from this Call. 

This Call is effective as of the date of this posting, 18 February 2022. White papers are due no later than 5:00 p.m. Eastern Standard Time (EST) on 10 March 2022. Please submit white papers via email to the Contracting POCs for the Call, Ms. Marina Schemmel at marina.schemmel@us.af.mil and Ms. Kimberly Cerney at kimberly.cerney@us.af.mil. 

Technical POC for this Call:  Mr. Nathaniel Baldwin, nathaniel.baldwin.1@us.af.mil

Contracting POCs for this Call:  Ms. Marina Schemmel, marina.schemmel@us.af.mil and Ms. Kimberly Cerney, kimberly.cerney@us.af.mil

________________________________________________________________________________________________________

The Warfighter Medical Optimization Division (RHM) intends to solicit White Papers under this announcement with the focus of conducting medical research in support of optimizing the warfighter by enabling, enhancing, restoring, and sustaining the Airman to more effectively execute the Air Force mission. This medical research objective is dual natured: (1) ensure medical availability of Airmen by analyzing attributes (sensory, behavioral, physiologic) and operational environments (chemical, physical, psychological, biological, radiological stressors) to drive optimal performance of Airmen engaged in high-demand, high-impact mission tasks (2) investigate how the flight environment affects the process of life, the ability to maintain homeostasis, and the risk for injury or secondary insult, seeking to ameliorate these stressors to optimize Airman health and performance.

This BAA will remain open for seventy-two (72) months with Calls being released throughout the seventy-two (72) month period of performance. 

This is Call 1, "Joint Multi-channel Infusion Pump (JMCIP)" to the initial Broad Agency Announcement (BAA), FA8650-20-S-6008. This is a Two-Step Call for the specific research objective 4, Expeditionary Medicine (EM), Aim 2, Medical Logistics of the BAA. Research objective 4, Aim 2, will be closed off from the Open BAA Period until award of the resulting proposal(s) from this Call. 

This Call is effective as of the date of this posting, 18 February 2022. White papers are due no later than 5:00 p.m. Eastern Standard Time (EST) on 10 March 2022. Please submit white papers via email to the Contracting POCs for the Call, Ms. Marina Schemmel at marina.schemmel@us.af.mil and Ms. Kimberly Cerney at kimberly.cerney@us.af.mil. 

Technical POC for this Call:  Mr. Nathaniel Baldwin, nathaniel.baldwin.1@us.af.mil

Contracting POCs for this Call:  Ms. Marina Schemmel, marina.schemmel@us.af.mil and Ms. Kimberly Cerney, kimberly.cerney@us.af.mil

________________________________________________________________________________________________________

The Warfighter Medical Optimization Division (RHM) intends to solicit White Papers under this announcement with the focus of conducting medical research in support of optimizing the warfighter by enabling, enhancing, restoring, and sustaining the Airman to more effectively execute the Air Force mission. This medical research objective is dual natured: (1) ensure medical availability of Airmen by analyzing attributes (sensory, behavioral, physiologic) and operational environments (chemical, physical, psychological, biological, radiological stressors) to drive optimal performance of Airmen engaged in high-demand, high-impact mission tasks (2) investigate how the flight environment affects the process of life, the ability to maintain homeostasis, and the risk for injury or secondary insult, seeking to ameliorate these stressors to optimize Airman health and performance.

This BAA will remain open for seventy-two (72) months with Calls being released throughout the seventy-two (72) month period of performance. 

This is Call 1, "Joint Multi-channel Infusion Pump (JMCIP)" to the initial Broad Agency Announcement (BAA), FA8650-20-S-6008. This is a Two-Step Call for the specific research objective 4, Expeditionary Medicine (EM), Aim 2, Medical Logistics of the BAA. Research objective 4, Aim 2, will be closed off from the Open BAA Period until award of the resulting proposal(s) from this Call. 

This Call is effective as of the date of this posting, 18 February 2022. White papers are due no later than 5:00 p.m. Eastern Standard Time (EST) on 10 March 2022. Please submit white papers via email to the Contracting POCs for the Call, Ms. Marina Schemmel at marina.schemmel@us.af.mil and Ms. Kimberly Cerney at kimberly.cerney@us.af.mil. 

Technical POC for this Call:  Mr. Nathaniel Baldwin, nathaniel.baldwin.1@us.af.mil

Contracting POCs for this Call:  Ms. Marina Schemmel, marina.schemmel@us.af.mil and Ms. Kimberly Cerney, kimberly.cerney@us.af.mil

_____________________________________________________________________

The Warfighter Medical Optimization Division (RHM) intends to solicit White Papers under this announcement with the focus of conducting medical research in support of optimizing the warfighter by enabling, enhancing, restoring, and sustaining the Airman to more effectively execute the Air Force mission. This medical research objective is dual natured: (1) ensure medical availability of Airmen by analyzing attributes (sensory, behavioral, physiologic) and operational environments (chemical, physical, psychological, biological, radiological stressors) to drive optimal performance of Airmen engaged in high-demand, high-impact mission tasks (2) investigate how the flight environment affects the process of life, the ability to maintain homeostasis, and the risk for injury or secondary insult, seeking to ameliorate these stressors to optimize Airman health and performance.

This BAA will remain open for seventy-two (72) months with Calls being released throughout the seventy-two (72) month period of performance. 

The Warfighter Medical Optimization Division (RHM) intends to solicit White Papers under this announcement with the focus of conducting medical research in support of optimizing the warfighter by enabling, enhancing, restoring, and sustaining the Airman to more effectively execute the Air Force mission. This medical research objective is dual natured: (1) ensure medical availability of Airmen by analyzing attributes (sensory, behavioral, physiologic) and operational environments (chemical, physical, psychological, biological, radiological stressors) to drive optimal performance of Airmen engaged in high-demand, high-impact mission tasks (2) investigate how the flight environment affects the process of life, the ability to maintain homeostasis, and the risk for injury or secondary insult, seeking to ameliorate these stressors to optimize Airman health and performance.

This BAA will remain open for seventy-two (72) months with Calls being released throughout the seventy-two (72) month period of performance.